LIFE - aTyr Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LIFE is currently covered by 1 analysts with an average price target of $16. This is a potential upside of $18.04 (-60.28%) from yesterday's end of day stock price of $40.28.

aTyr Pharma's activity chart (see below) currently has 17 price targets and 32 ratings on display. The stock rating distribution of LIFE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.17% with an average time for these price targets to be met of 1222.91 days.

Highest price target for LIFE is $16, Lowest price target is $16, average price target is $16.

Most recent stock forecast was given by RONALD JOSEY from CITI on 26-Feb-2026. First documented stock forecast 14-May-2018.

Currently out of the existing stock ratings of LIFE, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-Feb-2026

$16

$-5.71 (-26.30%)

$15

6 months 20 days ago
(26-Feb-2026)

2/2 (100%)

$3.72 (30.29%)

51

Buy Since 08-Oct-2018

$20

$-1.71 (-7.88%)

2 years 1 months 1 days ago
(14-Aug-2024)

9/9 (100%)

$20 (0.00%)

1372

Buy Since 29-May-2024

$22

$0.29 (1.34%)

2 years 3 months 17 days ago
(29-May-2024)

1/1 (100%)

$22 (0.00%)

707

Buy Since 13-Sep-2021

$35

2 years 4 months 1 days ago
(14-May-2024)

3/6 (50%)

$35 (0.00%)

1885

Buy Since 02-Mar-2020

$25

3 years 2 months 10 days ago
(05-Jul-2023)

3/7 (42.86%)

$25 (0.00%)

1975

Show more analysts

Please expand the browser size to see the chart

What is LIFE (aTyr Pharma) average time for price targets to be met?

On average it took 1,223 days for the stock forecasts to be reached, with an average price target met ratio of 51.17%.

Which analyst most recently updated their price target on LIFE (aTyr Pharma)?

Ronald Josey

Which analyst has the most public recommendations on LIFE (aTyr Pharma)?

Ronald Josey works at CITI and has 21 price targets and 16 ratings on LIFE

Which analyst is the currently most bullish on LIFE (aTyr Pharma)?

Kennen Mackay with the highest potential upside of $6.19

Which analyst is the currently most reserved on LIFE (aTyr Pharma)?

Joel Beatty with the lowest potential downside of -$10.06

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?